A Phase I Study of BI 836858 in Patients with Relapsed or Refractory Acute Myeloid Leukemia
[Protocol 12-133] |
Tallman, Martin |
- Leukemia
- Acute Myelocytic Leukemia
- Acute Myelogenous Leukemia
|
A Phase I Study of AZD6244 in Pediatric Patients with Recurrent or Refractory Low-Grade Glioma (PBTC-029)
[Protocol 12-151] |
Dunkel, Ira |
|
A Phase I Study of AZD4547 in Patients with Advanced Squamous Cell Lung Cancer
[Protocol 11-170] |
Paik, Paul |
- Lung Cancer
- Lung Cancer, Non-Small Cell
|
A Phase I Study of Axitinib plus Dalantercept for Patients with Metastatic Kidney Cancer
[Protocol 12-255] |
Voss, Martin |
|
A Phase I Study of AT13387 Alone or with Abiraterone to Treat Castration-Resistant Prostate Cancer that Continues Growing Despite Abiraterone
[Protocol 12-248] |
Slovin, Susan |
- Prostate Cancer
- Metastatic Disease after Hormone-Reducing Therapy
|
A Phase I Study of ASG-5ME Therapy Patients with Advanced Prostate Cancer
[Protocol 10-138] |
Morris, Michael |
- Prostate Cancer
- Metastatic Disease after Hormone-Reducing Therapy
|
A Phase I Study of ARN-810 in Postmenopausal Women with Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer
[Protocol 13-049] |
Dickler, Maura |
|
A Phase I Study of Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma
[Protocol 09-011] |
Modak, Shakeel |
|
A Phase I Study of an mRNA-Modified Dendritic Cell Vaccine in Patients with Melanoma
[Protocol 10-229] |
Young, James |
|
A Phase I Study of AMP-224 with a Cyclophosphamide-Containing Regimen in Patients with Advanced Melanoma
[Protocol 12-127] |
Dickson, Mark |
|
A Phase I Study of AGS-22M6E in Patients with Malignant Solid Tumors Expressing Nectin-4
[Protocol 11-113] |
Konner, Jason |
|
A Phase I Study of AGS-16C3F in Patients with Clear Cell or Papillary Renal Cell Cancer
[Protocol 12-162] |
Molina, Ana Maria |
|
A Phase I Study of Afatinib with Chemotherapy and Radiation Therapy in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
[Protocol 12-279] |
Chaft, Jamie |
- Lung Cancer, Non-Small Cell
|
A Phase I Study of AEB071 in Patients with Metastatic Uveal Melanoma
[Protocol 11-167] |
Schwartz, Gary |
|
A Phase I Study of AEB071 in Patients with CD79-Mutant Diffuse Large B-Cell Lymphoma
[Protocol 12-157] |
Gerecitano, John |
|
A Phase I Study of Actinium-225-Labeled HuM195 Antibody in Patients with Advanced Myeloid Malignancies
[Protocol 02-017] |
Douer, Dan |
- Hematology
- Leukemia
- Acute Myelogenous Leukemia
- Chronic Myelocytic Leukemia
- Myelodysplastic Syndrome
|
A Phase I Study of AC220 plus Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia
[Protocol 11-160] |
Tallman, Martin |
- Leukemia
- Acute Myelocytic Leukemia
- Acute Myelogenous Leukemia
|
A Phase I Study of AC220 for Children with Relapsed or Refractory Acute Leukemias
[Protocol 12-141] |
Trippett, Tanya |
- Leukemia
- Acute Lymphoblastic Leukemia
- Acute Myelogenous Leukemia
|
A Phase I Study of ABT-888 with Carboplatin and Paclitaxel in Patients with Solid Tumors Who Have Liver or Kidney Problems
[Protocol 11-118] |
Hyman, David |
|
A Phase I Study of ABT-888 in Combination with Carboplatin and Gemcitabine in Patients with Advanced Solid Tumors
[Protocol 09-154] |
Bell-McGuinn, Katherine |
|
